Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Innov Pharm ; 14(2)2023.
Artículo en Inglés | MEDLINE | ID: mdl-38025175

RESUMEN

Objectives: Immigration of Arabs to the United States has increased in recent years due to political instability and need for improved access to healthcare. Cardiovascular disease, diabetes, and obesity disproportionally affect Arab Americans. Student pharmacists are well positioned to increase health awareness by providing health screening services and education classes to the Arab immigrant community. This report will describe the development of a student-run Arab American Health Awareness Program (AAHAP) that provides culturally-sensitive community screening services targeting common health disparities seen among Arab-Americans. Design: Data were collected on the number of patient cardiometabolic screenings, referrals for medical care, and health classes which were performed over the course of 2 years. The practice setting included community centers, faith-based centers, and grocery stores in the Chicago area participating in the AAHAP. Results: Over the course of two years, eight cardiometabolic screenings and four community health classes were provided to the Arab-American community. Over 100 student pharmacists provided screenings to 929 patients through AAHAP. Twenty percent (n=193) of all patients screened were referred for further medical care. A total of 77% patients were within goal for blood pressure, 82.3% for blood glucose, and 39.4% for BMI. Patients with a known history of hypertension (n=83) or diabetes (n=64) were more likely to have uncontrolled blood pressure (45% vs 11%, p<0.05) or blood glucose (39% vs 14%, p<0.05) compared to patients without a history of these chronic conditions. Conclusion: Student pharmacists can be drivers for health access through community health programs for ethnically minoritized populations. Development of a health awareness program focused on known health disparities in Arab Americans has provided student pharmacists with opportunities to deliver culturally-sensitive care and medical referral services to an underserved community.

2.
Am J Pharm Educ ; 83(8): 7027, 2019 10.
Artículo en Inglés | MEDLINE | ID: mdl-31831894

RESUMEN

Objective. To design and implement an elective course that prepares student pharmacists to provide culturally sensitive health care by developing their knowledge, self-confidence, and clinical and communication skills for working with patients from various cultural backgrounds during community health screenings. Methods. In this one-credit-hour elective course, second- and third-year pharmacy students were taught about chronic disease states affecting various minorities, approaches to improve their communication with patients from various cultural backgrounds, and proper use of cardiometabolic equipment during health screening events. After a health screening event at the end of the course, knowledge scores, self-confidence, clinical skills, and communication skills were compared between students who took the elective course and those in a control group. A pre-post elective survey was administered to second- and third-year students enrolled in the elective course to assess differences in understanding, self-confidence, clinical skills, and communication skills. Results. The 31 students who completed the elective course performed better on the knowledge quiz questions than did the 31 students in the control group (response rate 100%). Self-confidence, and communication and clinical skills scores were higher among those who completed the elective course than those who did not. There was an increase in knowledge scores for all students enrolled in the course. Second-year students were just as confident in their abilities as third-year students by the end of course. Conclusion. An elective course focused on better preparing students to provide culturally sensitive health awareness through community health screenings improved students' overall knowledge, clinical skills, communication skills, and self-confidence.


Asunto(s)
Competencia Clínica/estadística & datos numéricos , Curriculum/estadística & datos numéricos , Atención a la Salud/estadística & datos numéricos , Educación en Farmacia/métodos , Estudiantes de Farmacia/estadística & datos numéricos , Adulto , Actitud del Personal de Salud , Comunicación , Evaluación Educacional/estadística & datos numéricos , Femenino , Humanos , Masculino , Evaluación de Programas y Proyectos de Salud/estadística & datos numéricos , Encuestas y Cuestionarios
3.
Int J Antimicrob Agents ; 49(5): 650-654, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28279787

RESUMEN

Methicillin-susceptible Staphylococcus aureus (MSSA) infections have been successfully treated both with cefazolin and antistaphylococcal penicillins; cefazolin appears effective in MSSA bloodstream infections (BSIs). Thus, our antimicrobial stewardship programme (ASP) implemented a clinical pathway supporting cefazolin use in MSSA-BSIs and restricting oxacillin use to infectious diseases (ID) consultation due to cefazolin's lower cost and more convenient dosing. This before and after quasi-experimental study was conducted to describe the impact on outcomes and process of care measures associated with implementing this pathway among patients with MSSA-BSI. Definitive treatment with cefazolin increased over the study period from 17.3% to 69.8% post-implementation. Clinical failure (5.8% vs. 2.3%; P = 0.62) and in-hospital mortality (3.8% vs. 0%; P = 0.50) were rare pre- and post-implementation. Median hospital length of stay among survivors was similar between pre- and post-implementation periods (P = 0.31). Duration of bacteraemia [median (IQR) 3 (2-4) days vs. 2 (2-3) days; P = 0.002] and rates of re-infection after culture clearance (9.6% vs. 0%; P = 0.06) were reduced post-implementation. Frequency of source control (P = 0.71) and time to source control (P = 0.52) were similar between study periods. Significant increases in ID consultations (33.3% [3/9] vs. 73.3% [22/30]; P = 0.047) and median (IQR) 24-h daily doses [2 (1-3) g vs. 6 (3-6) g; P < 0.01] were seen for patients treated with cefazolin post-implementation. ASPs may find implementation of a similar pathway to be an effective means of improving the care of patients infected with MSSA.


Asunto(s)
Antibacterianos/uso terapéutico , Programas de Optimización del Uso de los Antimicrobianos , Bacteriemia/tratamiento farmacológico , Cefazolina/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus/efectos de los fármacos , Bacteriemia/microbiología , Femenino , Mortalidad Hospitalaria , Humanos , Masculino , Meticilina/uso terapéutico , Persona de Mediana Edad , Oxacilina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA